bpc 157 and tb 500 nasal spray BPC157/TB500 TB-500 Nasal Spray | Research
Description
Why Choose the 250 ml Size
A 2025 preliminary safety study administered intravenous BPC-157 to 2 participants at escalating doses with no adverse effects reported, but the extremely limited sample size prevents meaningful conclusions
As mentioned, BPC 157 may interfere with the early events (i.e., immediate application after lidocaine) [60]
At 2mg five times weekly, 100mg lasts about 10 weeks, covering most protocols
